New gum fix could spare patients from tissue grafts
NCT ID NCT06643507
First seen Mar 29, 2026 · Last updated Jun 23, 2026 · Updated 15 times
Summary
This study tests a new way to treat multiple receding gums using a substance made from the patient's own blood (Alb-PRF) compared to the standard connective tissue graft. 26 adults with good oral hygiene will be treated and followed to see how much gum coverage is achieved. The goal is to find a less invasive option that still works well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GINGIVAL RECESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Dentistry Cairo University
RECRUITINGCairo, 4240101, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Albumin-platelet rich fibrin (Alb-PRF) and connective tissue graft (CTG)
What this could lead to
If it works, this could offer a less invasive, effective option for treating multiple gum recessions, potentially reducing the need for tissue grafts.
What could go wrong
This is a small, early-phase trial with only 26 people. The new method may not work better than the standard graft, and results may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.